We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

70 hedge funds and large institutions have $1.3B invested in Cullinan Oncology in 2021 Q1 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

75.66% more ownership

Funds ownership: 0% → 75.66% (+76%)

Holders
70
Holders Change
+70
Holders Change %
–
% of All Funds
1.23%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
70
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MB
MPM BioImpact
Massachusetts
+$321M
2
FCMV
Foresite Capital Management V
California
+$111M
3
CA
CHI Advisors
New York
+$89.4M
4
BG
Baupost Group
Massachusetts
+$74.5M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$49.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MB
1
MPM BioImpact
Massachusetts
$330M +$321M +7,913,887 New
FCMV
2
Foresite Capital Management V
California
$114M +$111M +2,731,410 New
CA
3
CHI Advisors
New York
$91.8M +$89.4M +2,202,407 New
BG
4
Baupost Group
Massachusetts
$71.7M +$74.5M +1,835,560 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$50.8M +$49.5M +1,220,174 New
EAM
6
Eventide Asset Management
Massachusetts
$49M +$49.2M +1,212,555 New
VA
7
VR Adviser
New York
$49M +$47.7M +1,176,145 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$48M +$46.7M +1,151,287 New
O
9
OrbiMed
New York
$47.8M +$46.5M +1,146,145 New
RSCM
10
Rock Springs Capital Management
Maryland
$44.8M +$43.7M +1,075,912 New
BC
11
Boxer Capital
California
$44.8M +$43.6M +1,074,082 New
BI
12
BVF Inc
California
$43.7M +$42.6M +1,049,356 New
BlackRock
13
BlackRock
New York
$37M +$36M +887,808 New
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$30.2M +$29.4M +723,584 New
APM
15
Avidity Partners Management
Texas
$29.5M +$28.7M +707,359 New
WP
16
Woodline Partners
California
$22.6M +$22M +542,912 New
Franklin Resources
17
Franklin Resources
California
$20.3M +$19.8M +488,308 New
LGM
18
Logos Global Management
California
$17.2M +$16.8M +413,458 New
Millennium Management
19
Millennium Management
New York
$16.8M +$16.4M +403,836 New
RCM
20
RA Capital Management
Massachusetts
$14.6M +$14.2M +350,000 New
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$14.2M +$13.9M +341,731 New
VC
22
Vivo Capital
California
$10.4M +$10.1M +250,000 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$9.18M +$8.94M +220,267 New
PVI
24
Pura Vida Investments
New York
$9.03M +$8.79M +216,630 New
State Street
25
State Street
Massachusetts
$8.12M +$7.91M +194,815 New
1
2 3

CGEM Hedge Fund Activity: Q1 2021 in Review

70 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q1 2021, worth a combined $1.3B.

Buyers outnumbered sellers: 70 funds opened new CGEM positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $321M.

  • 70 institutional investors held Cullinan Oncology (CGEM) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $1.3B of Cullinan Oncology stock for Q1 2021.
  • 70 funds opened new Cullinan Oncology positions in Q1 2021 and 0 closed out, a net change of +70 holders.
  • The largest Cullinan Oncology buyer in Q1 2021 was MPM BioImpact, an estimated $321M added.

Based on aggregated 13F filings for Q1 2021.